Vericel (VCEL) Shares Outstanding (Entity) (2010 - 2026)
Powered by 
Analysis
Vericel (VCEL) Shares Outstanding (Entity) (2010 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Entity.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Krystal Biotech | 10.20 Bn | 9.36 Bn | 112.79 Mn | 29.60 Mn |
| 2 | CRISPR Therapeutics AG | 5.20 Bn | 5.20 Bn | - | 96.66 Mn |
| 3 | Iovance Biotherapeutics | 3.79 Bn | 3.50 Bn | 55.72 Mn | 452.97 Mn |
| 4 | Legend Biotech | 3.68 Bn | 2.72 Bn | 251.50 Mn | - |
| 5 | uniQure | 3.07 Bn | 3.07 Bn | 5.49 Mn | 69.33 Mn |
| 6 | Beam Therapeutics | 2.67 Bn | 2.67 Bn | - | 103.26 Mn |
| 7 | Precigen | 2.43 Bn | 2.43 Bn | 52.17 Mn | 358.01 Mn |
| 8 | Sarepta Therapeutics | 2.33 Bn | 1.54 Bn | 251.87 Mn | 105.62 Mn |
| 9 | Vericel | 2.00 Bn | 1.84 Bn | 56.40 Mn | 51.17 Mn |
| 10 | Taysha Gene Therapies | 1.97 Bn | 1.97 Bn | - | 325.30 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 51.17 Mn |
| Mar 31, 2026 | 51.01 Mn |
| Dec 31, 2025 | 50.62 Mn |
| Sep 30, 2025 | 50.55 Mn |
| Jun 30, 2025 | 50.44 Mn |
| Mar 31, 2025 | 50.25 Mn |
| Dec 31, 2024 | 49.63 Mn |
| Sep 30, 2024 | 49.27 Mn |
| Jun 30, 2024 | 48.86 Mn |
| Mar 31, 2024 | 48.49 Mn |
| Dec 31, 2023 | 47.83 Mn |
| Sep 30, 2023 | 47.68 Mn |
| Jun 30, 2023 | 47.62 Mn |
| Mar 31, 2023 | 47.51 Mn |
| Dec 31, 2022 | 47.25 Mn |
| Sep 30, 2022 | 47.20 Mn |
| Jun 30, 2022 | 47.14 Mn |
| Mar 31, 2022 | 47.08 Mn |
| Dec 31, 2021 | 46.88 Mn |
| Sep 30, 2021 | 46.77 Mn |